Group 1 - The company, Tian Su Measurement (301449.SZ), is planning to issue 16,304,348 shares, which will account for 25% of the total share capital after the issuance [1] - The initial strategic placement will involve 2,445,651 shares, representing 15% of the total issuance, with participation from senior management and core employees [1] - The company aims to raise a total of 424 million yuan through this issuance, which will be allocated to various projects including enhancing measurement capabilities and establishing regional laboratories [2] Group 2 - The company operates as a national, comprehensive independent third-party measurement and testing service provider, serving multiple sectors such as biomedicine, automotive, and new energy [2] - The net profit attributable to the parent company has shown a continuous upward trend, with figures of 84.39 million yuan, 101.25 million yuan, 111.06 million yuan, and 55.58 million yuan over the reporting periods [2] - The revenue from the company's strategic focus on new energy battery testing has grown significantly, from 52.54 million yuan in 2022 to 113.14 million yuan in 2024, reflecting a compound annual growth rate of 46.75% [2]

Core Viewpoint - The company, Green Biological Technology Co., Ltd., has submitted its third IPO application for the ChiNext board after two previous unsuccessful attempts, facing multiple challenges including regulatory penalties and issues with information disclosure [3][41]. Company Overview - Green Biological was established in 1999 and has developed a product system comprising three main series: turpentine, cedarwood oil, and fully synthetic products. It is a significant supplier of sandalwood fragrance products in China and one of the largest suppliers of methyl cedar ketone [4][41]. - The company has long-term partnerships with major clients such as Givaudan, International Flavors & Fragrances, and Procter & Gamble, with the top five customers accounting for approximately 43.98% to 40.51% of sales from 2022 to 2025 [5][43]. Financial Performance - The company reported revenues of 5.4 billion, 5.94 billion, and 6.31 billion yuan from 2020 to 2022, with net profits of 644.3 million, 407.4 million, and 681.4 million yuan respectively. The gross profit margins ranged from 20.37% to 26.6% during the same period [56][57]. - For the first half of 2025, the company expects to raise 690 million yuan through its IPO, with plans to invest in expanding production capacity and upgrading facilities [41][34]. IPO Attempts and Challenges - The first IPO attempt in December 2020 was withdrawn within two months due to undisclosed environmental penalties and a significant expected drop in net profit for 2021 [9][11][50]. - The second attempt in June 2023 also faced scrutiny, leading to a withdrawal in September 2024 after two rounds of inquiries from the Shenzhen Stock Exchange regarding compliance and governance issues [56][58]. Governance and Succession - The founder, Lu Wencao, is currently 83 years old, raising concerns about the company's governance and succession planning. His daughter, Lu Wei, has been involved in the company since 2016 and is set to inherit a significant portion of shares [20][58]. Research and Development - The company's R&D expenditure has consistently been below 4% of revenue, which is lower than the industry average. The R&D costs from 2017 to 2025 were reported to be between 2.34% and 3.78% of revenue [25][26]. - There has been a notable increase in personnel costs within R&D, with 2024 showing a 109% increase compared to 2023, raising concerns about the allocation of R&D funds [27][29]. Cash Dividends and Financial Health - Despite ongoing cash dividends, the company has a significant amount of short-term debt and a low level of liquid assets, indicating potential liquidity issues. The total cash dividends from 2018 to 2024 amounted to 249 million yuan, which is 46.98% of the total net profit during that period [31][32][34]. - The company has maintained a high dividend payout ratio, with dividends exceeding net profits in some years, raising questions about its financial sustainability [31][32].

Core Viewpoint - The IPO application of Xinqiang Electronics (Qingyuan) Co., Ltd. has been terminated as the company and its sponsor withdrew the application, according to the Shenzhen Stock Exchange [1][2]. Company Overview - Xinqiang Electronics was established in August 2005 and is located in Qingyuan, Guangdong. The company specializes in the research, production, and sales of printed circuit boards (PCBs), focusing on the mid-to-high-end market, particularly high-end PCBs with eight layers or more [3]. - The average price of the company's products exceeds 2000 yuan per square meter, placing it in the top tier of the industry. The company has a strong reputation and brand advantage in the storage and communication sectors [3]. Financial Performance - The company's revenue from PCB products in the storage sector accounts for approximately 60% to 70% of its total revenue. In 2024, the company is expected to hold a market share of about 12.57% in the global memory module PCB market and 2.57% in the global SSD PCB market [4]. - The company's operating revenues for the years 2022 to 2024 are projected to be 868.73 million yuan, 1 billion yuan, and 998.91 million yuan, respectively. The net profits attributable to the parent company for the same period are expected to be 84.98 million yuan, 131.95 million yuan, and 167.92 million yuan [4]. Financial Metrics - As of December 31, 2024, the total assets of the company are projected to be 1.11 billion yuan, with equity attributable to the parent company at 837.13 million yuan. The asset-liability ratio is expected to be 24.97% [5]. - The company plans to raise 9.62 billion yuan for the "High-Density Interconnection PCB Expansion Project" [6].

Core Viewpoint - Luoyang Bearing Group Co., Ltd. (referred to as "Luoyang Bearings") has received acceptance for its IPO on the ChiNext board, aiming to raise 1.8 billion yuan for various development projects and debt repayment [1][2]. Financial Performance - Luoyang Bearings has shown a continuous increase in profitability, with projected revenues of 3.342 billion yuan, 4.441 billion yuan, 4.675 billion yuan, and 2.821 billion yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively [1]. - The net profit attributable to shareholders is expected to be -67.329 million yuan, 231 million yuan, 251 million yuan, and 257 million yuan for the same periods, indicating a trend of growth [1]. IPO Fund Utilization - The IPO proceeds of 1.8 billion yuan will primarily be allocated to the development and application of high-speed train bogie bearings, intelligent production construction for new energy bearings, precision bearing industry upgrades, and the industrialization of high-end precision small turntable bearings, as well as repaying bank loans [1]. Competitive Positioning - The implementation of the proposed projects is expected to enhance the company's competitive capabilities and sustainable development, solidifying its advantages in major equipment bearings and new energy vehicle bearings [2]. - The company aims to support potential market expansions in high-speed train bearings, high-end CNC machine tool bearings, and robot bearings through improved R&D, production capacity, and financial resources [2].

Core Viewpoint - Green Biological Technology Co., Ltd. is making a third attempt to launch an IPO on the ChiNext board after two previous failures, with the latest application accepted by the Shenzhen Stock Exchange on November 21 [1] Group 1: Company Overview - Green Biological has focused on the research, production, and sales of fragrance products since its establishment [1] - The company aims to raise approximately 690 million yuan through this IPO, which will be allocated to various projects including a 6,300-ton high-end fragrance production project, smart factory upgrades, R&D innovation, and working capital [1] Group 2: IPO History - The company’s first IPO attempt was accepted in December 2020 but was withdrawn in February 2021 [1] - After a gap of over two years, the second attempt was made in June 2023, which was also accepted but was withdrawn again in September 2024 after more than a year of processing [1]

Fundraising Adjustment Overview - A total of 33 companies have undergone fundraising adjustments during their IPO processes since 2025, with 5 companies reducing their fundraising amounts [1][29] Company-Specific Adjustments 1. Suzhou New Guangyi Electronics Co., Ltd. - The total fundraising amount was reduced from 800 million to 638 million, a decrease of 162 million, and the number of projects was cut from 2 to 1, focusing on functional materials [3][4] - The adjustment aims to strengthen core business and mitigate competition risks by concentrating resources on traditional advantages in functional materials [4] 2. Nabichuan New Energy Co., Ltd. - The total fundraising amount decreased from 829 million to 729 million, a reduction of 100 million, with the number of projects reduced from 3 to 2 [8][9] - The adjustment reflects a response to regulatory concerns regarding production capacity and aims to focus on core strategic projects while addressing liquidity pressures [9] 3. Yunhan Xincheng (Shanghai) Internet Technology Co., Ltd. - The total fundraising amount was significantly reduced from 942 million to 522 million, a decrease of 420 million, and the number of projects was cut from 4 to 3 [13][14] - The adjustment was made to enhance the rationality of the IPO plan and respond to market skepticism regarding the necessity of the original fundraising for liquidity [14][15] 4. Nantong Taihe Chemical Co., Ltd. - The total fundraising amount was reduced from 1.754 billion to 1.045 billion, a decrease of 709 million, and the number of projects was cut from 5 to 2 [18][19] - The adjustment was driven by regulatory inquiries and the need to improve the rationality of fundraising projects, particularly in light of fluctuating performance [19] 5. Shenzhen Shihang New Energy Co., Ltd. - The first adjustment increased the total fundraising from 1.511 billion to 3.512 billion, a rise of 2.001 billion, while the second adjustment reduced it from 3.512 billion to 1.211 billion, a decrease of 2.301 billion [23][26] - The adjustments reflect strategic expansion needs and responses to regulatory inquiries regarding production capacity and market conditions [24][27] Summary of Trends - Companies are increasingly focusing on core business areas and reducing fundraising amounts in response to regulatory inquiries and market conditions [29][30] - The adjustments indicate a shift towards more prudent financial planning and a strategic focus on competitive advantages in their respective industries [30]

Core Viewpoint - Jinqiao Dek New Materials Co., Ltd. is pursuing an IPO on the ChiNext board, showing increasing revenue but decreasing sales concentration among its top five customers, alongside a significant proportion of accounts receivable relative to total assets [1][2][4]. Financial Performance - The company reported revenues of 491 million, 539 million, and 627 million yuan for the years 2022, 2023, and 2024 respectively, with net profits after deducting non-recurring items of 87.26 million, 114 million, and 135 million yuan for the same years [2][4]. - Total assets increased from 558.96 million yuan in 2022 to 911.80 million yuan in 2024, while equity attributable to shareholders rose from 411.95 million yuan to 642.49 million yuan during the same period [3][4]. - The company's net profit margin improved, with net profits of 91.31 million, 116.95 million, and 141.03 million yuan for 2022, 2023, and 2024 respectively [3][4]. Customer Concentration - Sales to the top five customers decreased from 53.73 million yuan in 2022 to 44.84 million yuan in 2024, with their contribution to total sales dropping from 10.94% to 7.15% [4]. - The sales amount to the largest customer also declined from 15.89 million yuan in 2022 to 11.15 million yuan in 2024, indicating a diversification in the customer base [4]. Accounts Receivable - Accounts receivable accounted for over 30% of total assets, with values of 214 million, 237 million, and 294 million yuan at the end of 2022, 2023, and 2024 respectively [4][6]. - The proportion of accounts receivable to total revenue was 43.53%, 44.08%, and 46.84% for the respective years, indicating a growing reliance on credit sales [4][6]. Cost Management - The gross profit margin improved from 34.23% in 2022 to 41.23% in 2024, primarily due to a decrease in raw material prices [9]. - The company's selling expense ratio was significantly lower than industry averages, at 4.17%, 4.49%, and 4.52% compared to the industry average of 11.71%, 9.91%, and 9.84% [9][10]. - Management expense ratios were also below industry averages, at 3.98%, 4.09%, and 4.51% compared to the industry averages of 9.72%, 8.93%, and 8.73% [9][10].

Core Viewpoint - Shenzhen Tian Su Measurement and Testing Co., Ltd. has successfully passed the IPO review for the ChiNext board, with China Merchants Securities as the sponsor [2]. Company Overview - Tian Su Measurement was established in 2009 and operates as an independent third-party measurement and testing service provider, focusing on calibration, testing, and certification services [4]. - The company's clients span various sectors, including biomedicine, automotive, new energy, rail transit, energy and power, light industry, and equipment manufacturing [4]. Financial Performance - The total assets of Tian Su Measurement have increased from 464.55 million yuan in 2022 to an estimated 729.19 million yuan by June 30, 2025 [5]. - The company's net profit has shown growth from 84.39 million yuan in 2022 to an estimated 55.58 million yuan in the first half of 2025 [5]. - The operating revenue for the years 2022 to 2025 is projected to be 597 million yuan, 726 million yuan, 800 million yuan, and 409 million yuan respectively [5]. Future Projections - For the first nine months of 2025, the company expects operating revenue to grow by approximately 9.89% to 12.49% compared to the same period in 2024 [6]. - The net profit attributable to the parent company is projected to increase by 8.03% to 11.04% year-on-year [6].

Core Viewpoint - Shenzhen Tian Su Measurement and Testing Co., Ltd. has successfully passed the IPO review for the ChiNext board, aiming to raise approximately 424 million yuan for various projects and working capital [1] Company Overview - Shenzhen Tian Su Measurement specializes in measurement calibration, testing, and certification services, serving multiple sectors including biomedicine, automotive, new energy, rail transportation, energy and power, light industry, and equipment manufacturing [1] IPO Details - The IPO application was accepted on June 29, 2023, and entered the inquiry stage on July 22, 2023 [1] - The company plans to invest the raised funds in enhancing measurement and testing capabilities at its Shenzhen headquarters, constructing regional measurement testing laboratories, developing a digital center, and supplementing working capital [1] Market Considerations - During the listing committee meeting, the committee requested the company to explain the sustainability of its performance growth in light of its high sales expense ratio and low R&D investment intensity, considering industry technological upgrades and competitive dynamics [1]

Core Viewpoint - Shenzhen TianSu Measurement and Testing Co., Ltd. has successfully passed the IPO review on the ChiNext board, aiming to raise approximately 424 million yuan for various projects and working capital [1] Company Overview - TianSu Measurement specializes in measurement calibration, testing, and certification services, serving multiple sectors including biomedicine, automotive, new energy, rail transit, energy and electricity, light industry, and equipment manufacturing [1] IPO Details - The IPO application was accepted on June 29, 2023, and entered the inquiry stage on July 22, 2023 [1] - The company plans to invest the raised funds in enhancing measurement and testing capabilities at its Shenzhen headquarters, building regional measurement testing laboratories, establishing a digital center, and supplementing working capital [1] Industry Considerations - The listing committee has requested TianSu Measurement to address the implications of its high sales expense ratio and low R&D investment intensity in relation to industry technological upgrades and the sustainability of its performance growth [1]